Related Experiment Video
Updated: Mar 29, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways
Pengfei Xu1, Yingjie Zhang1, Yunye Liu1
1Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.
Abstract:
Fibroblast growth factor 21 (FGF-21) is a secreted protein, which has anti-diabetic and lipocaic effects, but its ability to protect against hepatic fibrosis has not been studied. In this study, we investigated the ability of FGF-21 to attenuate dimethylnitrosamine (DMN)-induced hepatic fibrogenesis in mice and the mechanism of its action. Hepatic fibrosis was induced by injection of DMN, FGF-21 was administered to the mice once daily in association with DMN injection till the end of the experiment. Histopathological examination, tissue 4-hydroxyproline content and expressions of smooth muscle α-actin (α-SMA) and collagen I were measured to assess hepatic fibrosis. Ethanol/PDGF-BB-activated hepatic stellate cells (HSCs) were used to understand the mechanisms of FGF-21 inhibited hepatic fibrogenesis. Results showed that FGF-21 treatment attenuated hepatic fibrogenesis and was associated with a significant decrease in intrahepatic fibrogenesis, 4-hydroxyproline accumulation, α-SMA expression and collagen I deposition. FGF-21 treatment inhibited the activation of HSCs via down-regulating the expression of TGF-β, NF-κB nuclear translocation, phosphorylation levels of smad2/3 and IκBα. Besides, FGF-21 treatment caused activated HSC apoptosis with increasing expression of Caspase-3, and decreased the ratio of Bcl-2 to Bax. In conclusion, FGF-21 attenuates hepatic fibrogenesis and inhibits the activation of HSC warranting the use of FGF-21 as a potential therapeutic agent in the treatment of hepatic fibrosis.
Insights
Fibroblast growth factor 21 (FGF-21) shows promise in treating liver fibrosis. This study found FGF-21 effectively reduced liver fibrosis in mice by inhibiting hepatic stellate cell activation and promoting apoptosis.
Area of Science:
- Hepatology and Molecular Biology
- Endocrinology
Background:
- Fibroblast growth factor 21 (FGF-21) is known for its anti-diabetic and lipocaic effects.
- The protective role of FGF-21 against hepatic fibrosis remains uninvestigated.
Purpose of the Study:
- To investigate the efficacy of FGF-21 in attenuating dimethylnitrosamine (DMN)-induced hepatic fibrosis in a mouse model.
- To elucidate the underlying mechanisms by which FGF-21 exerts its antifibrotic effects.
Main Methods:
- Hepatic fibrosis was induced using DMN injections in mice, with concurrent daily administration of FGF-21.
- Assessment of fibrosis involved histopathology, 4-hydroxyproline content, and expression of α-SMA and collagen I.
- Mechanisms were explored using activated hepatic stellate cells (HSCs) treated with ethanol/PDGF-BB.
Main Results:
- FGF-21 treatment significantly attenuated hepatic fibrogenesis, reducing fibrosis markers like 4-hydroxyproline, α-SMA, and collagen I.
- FGF-21 inhibited HSC activation by downregulating TGF-β, NF-κB nuclear translocation, and smad2/3 and IκBα phosphorylation.
- FGF-21 induced apoptosis in activated HSCs, evidenced by increased Caspase-3 and altered Bcl-2/Bax ratio.
Conclusions:
- FGF-21 demonstrates significant antifibrotic effects in a DMN-induced mouse model.
- FGF-21 inhibits hepatic stellate cell activation and promotes their apoptosis, key mechanisms in reducing liver fibrosis.
- FGF-21 represents a potential therapeutic agent for treating hepatic fibrosis.
Related Concept Videos
TGF - β Signaling Pathway
Introduction to Fibroblasts
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of Angiogenesis and Blood Supply

